+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioCryst Pharmaceuticals Inc - logo

BioCryst Pharmaceuticals is a biotechnology company that designs and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst's core development programs include BCX7353 and additional 2nd generation oral inhibitors of plasma kallikrein for hereditary angioedema; and BCX4430 (GALIDESIVIR), a broad spectrum antiviral for hemorrhagic fevers. The company was founded in 1986 and is headquartered in Durham, North Carolina.

Yellow Fever - Pipeline Review, H2 2020 - Product Thumbnail Image

Yellow Fever - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 71 Pages
From
From
From
Zika Virus Infections - Pipeline Review, H1 2020 - Product Thumbnail Image

Zika Virus Infections - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 274 Pages
From
From
Refractory Leukemia Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Refractory Leukemia Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • June 2018
  • 71 Pages
From
T-Cell Lymphoma Market 2019-2025 - Product Thumbnail Image

T-Cell Lymphoma Market 2019-2025

  • Report
  • September 2020
From
From
From
Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2022 - Product Thumbnail Image

Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2022

  • Clinical Trials
  • March 2022
  • 80 Pages
From
From
Fibrodysplasia Ossificans Progressiva - Pipeline Insight, 2021 - Product Thumbnail Image

Fibrodysplasia Ossificans Progressiva - Pipeline Insight, 2021

  • Clinical Trials
  • October 2021
  • 60 Pages
From
From
From
Loading Indicator